Recent studies have revealed that Tacitracin (TG), a natural antiviral drug, was discovered by the same scientists. It can block viruses such as the original SARS-CoV-2.
Madrid. (European News). A plant-based antiviral treatment was recently discovered by scientists from the University of Nottingham in the UK. It is equally effective in treating all forms of the SARS CoV-2 virus, even the highly infectious Delta variant.
This new research, published in Virulence, shows that the Delta variant has the highest ability to multiply in cells, and the most potential to spread directly to nearby cells.
The reproduction of co-infected partners with two variants of SARS CoV-2 was also increased by the Delta variant.
Researchers also discovered that Tahigarin (TG) is a natural antiviral drug. It can block viruses such as the original SARS-CoV-2. It works equally well for all the new coronavirus varieties. Virus SARSCoV-2, including Delta variants.
The team previously demonstrated that a small amount of plant-derived antiviral drugs can trigger an immune response in the host against three types of respiratory viruses, including SARS-CoV-2 Innate.
This latest study was done by the team to examine the extent to which emerging variants SARS-CoV-2 and Alpha, Beta, and Delta can multiply in cells with co-infections and single-variant infections. Both variants were simultaneously infected to the cells. The team wanted to determine if TG was effective in preventing the emergence of these mutations.
The Delta variant has the greatest proliferation potential and the best ability to spread directly to other cells. Its expansion rate after 24 hours is greater than that of the Alpha variant (which is Beta 9 times).
Co-infection with the Delta variant increases the reproduction of its coinfected friends. The co-infection of Alpha, Delta, and Beta with other viruses can have a multiplicative effect on their proliferation. In this case, the total production of all new viruses is greater that the sum of any single variants.
SARS-CoV-2 is particularly sensitive to TG treatment. A single dose of TG administered before infection prevented 95% of all variant infections and all coinfections, compared to the control group. TG can be effective in inhibiting all variants during active infection.
“Our new research has allowed us to better understand the Delta variants. While we have clearly shown that this variant has the highest contagious potential and has facilitated co-infection of other variants, we are glad to announce that TG is equally effective in all variants. Together, these results indicate the antiviral potential of TG as a post-exposure prophylactic and active therapeutic agent,” explained the study’s lead author, Professor Kin Chow Chang.